Medtronic MiniMed, Inc. is recalling approximately 6,816 units of the InPen App for iOS and Android devices due to software design errors. These errors can cause the app to miss reminders for short-acting insulin doses or provide incorrect recommendations for correcting high blood sugar values. While the physical insulin pen still functions correctly for manual dosing and data recording, the app's software fails to provide necessary alerts, which was discovered during internal testing. No injuries or patient complaints have been reported in relation to this issue.
The software defect may prevent users from receiving critical insulin dose reminders or cause them to receive incorrect guidance for managing high glucose levels. This failure to alert the user can delay necessary diabetes treatment, potentially leading to high blood sugar (hyperglycemia).
You have 2 options:
Affected software versions: 7.0.0, 7.1.0, 7.2.0 and 7.5.0
Affected software versions: 7.0.0, 7.0.1, 7.1.0, 7.1.1, 7.2.0 and 7.5.0
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.